2nd generation test for breast cancer test designed from the foundation of breast cancer biology for precise and fast treatment decisions.

Provides more accurate prognostic information on the risk of distant recurrence among gene-expression and immunohistochemical biomarkers.

Recommended for：

• Patients who are early breast cancer (Stage I or II)
• Patients who are ER/PR+ ,and invasive lymph node ≤3.

Workflow

Ordering

Sample Collection

Transportation

Analysis Report

Icon reference: Arrow icons created by Creative Stall Premium - Flaticon